Stocks Health care NSPR
NASDAQ · Health careInspireMD, Inc. (NSPR)
InspireMD, Inc. brought in $10.8M of revenue over the twelve months to June 30, 2026, up 53.4% from a year earlier. It posted a net loss of $52.5M. In fiscal 2025 capital spending exceeded operating cash flow by $36.8M. At June 30, 2026 it held $15.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What InspireMD, Inc. does
InspireMD, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NSPR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $9M | -$48.8M | -$0.76 | -$36.8M |
| 2024 | $7M | -$32M | -$0.76 | -$23.3M |
| 2023 | $6.2M | -$19.9M | -$0.82 | -$16.8M |
| 2022 | $5.2M | -$18.5M | -$2.35 | -$16M |
| 2021 | $4.5M | -$14.9M | -$2.03 | -$13.6M |
| 2020 | $2.5M | -$10.5M | -$6.97 | -$9.2M |
Latest SEC filings
What InspireMD, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 21, 2026
- August 17, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026
- July 29, 2026
- July 23, 2026
- July 2, 2026
- June 11, 2026
- June 3, 2026
- May 22, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about NSPR
What does InspireMD, Inc. do?
InspireMD, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NSPR.
Is InspireMD, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $52.5M on revenue of $10.8M.
How much revenue does InspireMD, Inc. make?
Over the twelve months to June 30, 2026 InspireMD, Inc. reported revenue of $10.8M. That is 53.4% more than a year earlier.
When did InspireMD, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 23, 2026.
Similar companies
Follow NSPR
Get an email when InspireMD, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NSPR: get an email when it filesWhere the numbers come from
Financial figures are the values InspireMD, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.